JERSEY CITY, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. Continue reading →

Theres nobody Michael Lewis likes better than a hero who gives a defiant middle finger to the conventional wisdom: The short-seller who bets against a soaring mortgage market; the equities trader who insists that the stock exchange is rigged. And then theres Mr Lewis himself, who has made his own name and fortune by writing against expectations, taking arcane subjects that most of his mega-readership might know next to nothing about and skilfully unfurling their intricacies in all of their dramatic glory. Continue reading →

This article was originally published here Brain Pathol. Continue reading →

NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ending March 31, 2021 and recent company developments, along with a business outlook for 2021. Michael S. Continue reading →

TheMultiple Sclerosis Treatment MarketReport conveys the clean expounded structure of the Market including every single business-related data of the market at a worldwide level. The total scope of data identified with the Market is acquired through different sources and this got main part of data is orchestrated, handled, and spoken to by a gathering of authorities through the utilization of various methodological procedures and logical instruments, for example, SWOT analysis to produce an entire arrangement of exchange based examination in regards to the Multiple Sclerosis Treatment Market. Global multiple sclerosis treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Continue reading →

Jacqueline Claudia Barrientos, MD, MS, discusses treatment options for patients with chronic lymphocytic leukemia who harbor TP53 mutations or 17p deletions. Continue reading →

LEXINGTON, Mass., May 10, 2021 /PRNewswire/ --LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced the appointment of Andrea Paul as general counsel and corporate secretary and Janice Olson as senior vice president of strategy and portfolio management Continue reading →